Alzheimer's Association Awards $1 Million Grant to UK Sanders-Brown Center on Aging

Alzheimer's Association Awards $1 Million Grant to UK Sanders-Brown Center on Aging

Linda Van Eldik, director of the University of Kentucky Sanders-Brown Center on Aging, was awarded a "Part the Cloud" translational research grant from the Alzheimer's Association. This two-year, $997,738 grant will fund early clinical trials for a promising new treatment for Alzheimer's disease.

Sanders-Brown Research Hints at Underlying Cause for Alzheimer's Drug Trial Failures

Sanders-Brown Research Hints at Underlying Cause for Alzheimer's Drug Trial Failures

Because Alzheimer’s disease (AD) is the leading cause of dementia, many people use the two terms interchangeably. But inadequate blood flow to the brain due to microinfarcts, mini-strokes, or strokes is a hallmark of a disease called Vascular Cognitive Impairment and Dementia (VCID).

Identifying Biomarkers Key to Early Intervention in Alzheimer's Disease

Identifying Biomarkers Key to Early Intervention in Alzheimer's Disease

Although the term didn’t surface until the 1980s, the concept of biomarkers has been around for almost a century. Today, doctors routinely test blood for signs of anemia or the antigen associated with prostate cancer. Urine samples can hint at the presence of infection or diabetes, and EEGs diagnose electrical abnormalities in the brain.